AC Immune SA (ACIU) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

CHF 3.6M

Net Income/Loss (FY2025)

-CHF 70.4M

Total Assets (FY2025)

CHF 154.3M

Total Equity (FY2025)

CHF 44.9M

Cash Flows from Operating Activities (FY2025)

-CHF 69.3M

Source: AC Immune SA 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.